Strategies to target ADAM17 in disease: from its discovery to the iRhom revolution

M Calligaris, D Cuffaro, S Bonelli, DP Spanò… - Molecules, 2021 - mdpi.com
For decades, disintegrin and metalloproteinase 17 (ADAM17) has been the object of deep
investigation. Since its discovery as the tumor necrosis factor convertase, it has been …

The metalloprotease ADAM17 in inflammation and cancer

S Düsterhöft, J Lokau, C Garbers - Pathology-Research and Practice, 2019 - Elsevier
Proteolytic cleavage of transmembrane proteins is an important post-translational
modification that regulates the biological function of numerous transmembrane proteins …

The protease ADAM17 at the crossroads of disease: revisiting its significance in inflammation, cancer, and beyond

MI Saad, BJ Jenkins - The FEBS journal, 2024 - Wiley Online Library
The protease A Disintegrin And Metalloproteinase 17 (ADAM17) plays a central role in the
pathophysiology of several diseases. ADAM17 is involved in the cleavage and shedding of …

Cryo-EM reveals that iRhom2 restrains ADAM17 protease activity to control the release of growth factor and inflammatory signals

F Lu, H Zhao, Y Dai, Y Wang, CH Lee, M Freeman - Molecular Cell, 2024 - cell.com
A disintegrin and metalloprotease 17 (ADAM17) is a membrane-tethered protease that
triggers multiple signaling pathways. It releases active forms of the primary inflammatory …

ADAM17 activity and IL-6 trans-signaling in inflammation and cancer

N Schumacher, S Rose-John - Cancers, 2019 - mdpi.com
All ligands of the epidermal growth factor receptor (EGF-R) are transmembrane proteins,
which need to be proteolytically cleaved in order to be systemically active. The major …

The molecular, cellular and pathophysiological roles of iRhom pseudoproteases

I Dulloo, S Muliyil, M Freeman - Open biology, 2019 - royalsocietypublishing.org
iRhom proteins are catalytically inactive relatives of rhomboid intramembrane proteases.
There is a rapidly growing body of evidence that these pseudoenzymes have a central …

Degradome of soluble ADAM10 and ADAM17 metalloproteases

F Scharfenberg, A Helbig, M Sammel, J Benzel… - Cellular and Molecular …, 2020 - Springer
Disintegrin and metalloproteinases (ADAMs) 10 and 17 can release the extracellular part of
a variety of membrane-bound proteins via ectodomain shedding important for many …

[HTML][HTML] Status update on iRhom and ADAM17: It's still complicated

S Düsterhöft, A Babendreyer, AA Giese… - … et Biophysica Acta (BBA …, 2019 - Elsevier
Several membrane-bound proteins with a single transmembrane domain are subjected to
limited proteolysis at the cell surface. This cleavage leads to the release of their biologically …

Contribution of ADAM17 and related ADAMs in cardiovascular diseases

T Kawai, KJ Elliott, R Scalia, S Eguchi - Cellular and Molecular Life …, 2021 - Springer
A disintegrin and metalloproteases (ADAMs) are key mediators of cell signaling by
ectodomain shedding of various growth factors, cytokines, receptors and adhesion …

[HTML][HTML] Integrating GIS accessibility and location-allocation models with multicriteria decision analysis for evaluating quality of life in Buraidah city, KSA

A Abd El Karim, MM Awawdeh - Sustainability, 2020 - mdpi.com
The present study was aimed at evaluating the quality of life in the districts of Buraidah city in
the Kingdom of Saudi Arabia as part of the Kingdom's Vision 2030, based on provided …